Low-density lipoprotein cholesterol goal attainment in high-risk family medicine patients

Joseph P Vande Griend1, Joseph J Saseen

  • 1University of Colorado Denver, School of Pharmacy, 12631 East 17th Ave, Room 1411, Aurora, CO 80045 USA.

Insights

Defining "very high risk" for LDL-C goals varied significantly among patients with atherosclerotic vascular disease. Despite varied definitions, the rates of achieving a low-density lipoprotein-cholesterol (LDL-C) goal of <70mg/dl remained similar.

Area of Science:

  • Cardiology
  • Preventive Medicine
  • Clinical Risk Stratification

Background:

  • The Adult Treatment Panel III guideline suggests a low-density lipoprotein-cholesterol (LDL-C) goal of <100mg/dl for patients with coronary heart disease or risk equivalence.
  • An optional LDL-C goal of <70mg/dl is recommended for patients deemed "very high risk," but this category lacks clear definition, leading to varied clinical interpretations.

Purpose of the Study:

  • To define the

Main Methods:

  • Five distinct definitions of "very high risk" were developed to assess eligibility for an LDL-C goal of <70mg/dl.
  • Medical records of 445 patients with coronary heart disease or risk equivalence were retrospectively evaluated over two years.
  • Prevalence of "very high risk" and attainment of LDL-C <70mg/dl were assessed based on the five definitions.

Main Results:

  • Prevalence of "very high risk" varied significantly by definition, ranging from 10.8% (atherosclerotic vascular disease [AVD] plus smoking) to 67.2% (All AVD).
  • LDL-C <70mg/dl goal attainment rates showed no significant difference across the definitions, ranging from 26.7% to 46.3%.
  • A significant portion of patients, even under the broadest definition (All AVD), did not meet the <70mg/dl LDL-C goal.

Conclusions:

  • The classification of patients as "very high risk" is highly variable based on the definition used.
  • Variability in defining "very high risk" did not appear to impact the rates of achieving the LDL-C <70mg/dl goal.
  • Future guidelines, such as the forthcoming Adult Treatment Panel IV, should prioritize simplicity and clarity in defining patient risk and LDL-C goals for effective clinical application.
Abstract

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ meats, shellfish,...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...